baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BAYER AG NA O.N./ DE000BAY0017 /

09/10/2024 22:58:09	Chg. -1.925	Volume	Bid22:58:09	Ask22:58:09	Market Capitalization	Dividend Y.	P/E Ratio
27.280EUR	-6.59%	- Turnover: -	27.280Bid Size: -	27.335Ask Size: -	26.76 bill.EUR	0.40%	-

TeleTrader 16/08 Bayer jumps 10% after Roundup court win

GlobeNewswire 02/08 Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting A...

GlobeNewswire 11/07 AskBio receives FDA Fast Track and MHRA Innovation Passport designations for AB-1005 investigational...

GlobeNewswire 25/06 AskBio Initiates Recruitment to its Phase 2 Parkinson’s Disease Trial

GlobeNewswire 30/05 Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines

GlobeNewswire 30/05 BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...

GlobeNewswire 29/05 Lynch Carpenter Investigates Claims in Cencora, Inc. Data Breach

GlobeNewswire 28/05 Pairwise and Bayer Expand CRISPR Leafy Greens Market through Licensing Agreement

TeleTrader 14/05 Bayer's sales in Q1 at €13.7 billion, down 4.3%

GlobeNewswire 02/05 AskBio Announces Nine Presentations at American Society of Gene and Cell Therapy 27th Annual Meeting...

GlobeNewswire 18/04 AskBio receives FDA Fast Track Designation for AB-1002 investigational gene therapy program in conge...

GlobeNewswire 16/04 AskBio presents 18-month Phase Ib trial results of AB-1005 gene therapy for patients with Parkinson’...

GlobeNewswire 11/04 Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from...

GlobeNewswire 09/04 AskBio Names Mansuo Shannon Chief Scientific Officer

GlobeNewswire 25/03 BlueRock Therapeutics and Foundation Fighting Blindness announce collaboration to expand the Uni-Rar...

GlobeNewswire 14/03 Bayer and Aignostics to collaborate on next generation precision oncology

GlobeNewswire 06/03 BlueRock Therapeutics phase I clinical trial for Parkinson’s disease continues to show positive tren...

TeleTrader 05/03 Bayer's Q4 sales at €11.9 billion

GlobeNewswire 04/03 BridgeBio Pharma and Bayer Announce European Licensing Agreement for Acoramidis in ATTR-CM

TeleTrader 04/03 Earnings preview: Bayer, Broadcom among those in calendar

GlobeNewswire 15/02 2Blades Delivers on Project with Bayer Crop Science to Combat Asian Soybean Rust

GlobeNewswire 13/02 Corporate Alignment with Climate Goals Under Scrutiny: LyondellBasell & Bayer demonstrate good pract...

GlobeNewswire 13/02 First patient randomized in AskBio Phase II gene therapy trial for congestive heart failure

TeleTrader 29/01 Bayer down over 5% after latest $2.25B Roundup ruling

TeleTrader 17/01 Bayer to cut jobs amid 'difficult situation'

BAYER AG NA O.N./ DE000BAY0017 /

If you wish to receive reply to your feedback, please provide your email address.